Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-12-21

FDA Approved: SELEXIPAG — Original Application (Zydus Pharmaceuticals (USA) Inc.)

View source ↗

Summary

FDA approved the original ANDA for Selexipag from Zydus Pharmaceuticals (USA) Inc., providing a generic option for treating pulmonary arterial hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Selexipag (selexipag)

Snippet

ORIG AP for SELEXIPAG (SELEXIPAG)